BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28539160)

  • 1. Phosphorylation of p53 at threonine 155 is required for Jab1-mediated nuclear export of p53.
    Lee EW; Oh W; Song HP; Kim WK
    BMB Rep; 2017 Jul; 50(7):373-378. PubMed ID: 28539160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2.
    Oh W; Lee EW; Sung YH; Yang MR; Ghim J; Lee HW; Song J
    J Biol Chem; 2006 Jun; 281(25):17457-17465. PubMed ID: 16624822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
    Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY
    J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system.
    Bech-Otschir D; Kraft R; Huang X; Henklein P; Kapelari B; Pollmann C; Dubiel W
    EMBO J; 2001 Apr; 20(7):1630-9. PubMed ID: 11285227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jab1 has negative effects on p53-mediated genotoxic stresses.
    Lee EW; Lee S; Song J
    BMB Rep; 2009 May; 42(5):299-303. PubMed ID: 19470245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jab1 as a mediator of nuclear export and cytoplasmic degradation of p53.
    Lee EW; Oh W; Song J
    Mol Cells; 2006 Oct; 22(2):133-40. PubMed ID: 17085963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3.
    Kim JH; Choi JK; Cinghu S; Jang JW; Lee YS; Li YH; Goh YM; Chi XZ; Lee KS; Wee H; Bae SC
    J Cell Biochem; 2009 Jun; 107(3):557-65. PubMed ID: 19350572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcriptional cofactor Jab1/Cops5 is crucial for BMP-mediated mouse chondrocyte differentiation by repressing p53 activity.
    Mamidi MK; Samsa WE; Bashur LA; Chen Y; Chan R; Lee B; Zhou G
    J Cell Physiol; 2021 Aug; 236(8):5686-5697. PubMed ID: 33393086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The crucial p53-dependent oncogenic role of JAB1 in osteosarcoma in vivo.
    Samsa WE; Mamidi MK; Bashur LA; Elliott R; Miron A; Chen Y; Lee B; Greenfield EM; Chan R; Danielpour D; Zhou G
    Oncogene; 2020 Jun; 39(23):4581-4591. PubMed ID: 32390003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural characterization of As-MIF and hJAB1 during the inhibition of cell-cycle regulation.
    Park YH; Jeong MS; Ha KT; Yu HS; Jang SB
    BMB Rep; 2017 May; 50(5):269-274. PubMed ID: 28366190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma.
    Wang Y; Wang Y; Cheng C; Ji Y; Zhao Y; Zou L; Shen A
    J Cancer Res Clin Oncol; 2009 Jul; 135(7):951-9. PubMed ID: 19139918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer.
    Danielpour D; Purighalla S; Wang E; Zmina PM; Sarkar A; Zhou G
    Biochem Biophys Res Commun; 2019 Oct; 518(2):374-380. PubMed ID: 31434609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway.
    Zhu Y; Qiu Z; Zhang X; Qian F; Wang B; Wang L; Shi H; Yu R
    J Neurooncol; 2017 Jan; 131(1):31-39. PubMed ID: 27640199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A7, Jab1, and p27
    Granata M; Skarmoutsou E; Gangemi P; Mazzarino MC; D'Amico F
    J Cell Biochem; 2019 Mar; 120(3):3384-3392. PubMed ID: 30203426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAB1 regulates CPNE1-related differentiation via direct binding to CPNE1 in HiB5 hippocampal progenitor cells.
    Yoo JC; Park N; Choi HY; Park JY; Yi GS
    Biochem Biophys Res Commun; 2018 Feb; 497(1):424-429. PubMed ID: 29448099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Approach to Unraveling the Apoptotic Potential of Rutin (Bioflavonoid) via Targeting
    Pandey P; Khan F; Alzahrani FA; Qari HA; Oves M
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles for CSN5 in control of p53/MDM2 activities.
    Zhang XC; Chen J; Su CH; Yang HY; Lee MH
    J Cell Biochem; 2008 Mar; 103(4):1219-30. PubMed ID: 17879958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1.
    Tanaka Y; Kanai F; Ichimura T; Tateishi K; Asaoka Y; Guleng B; Jazag A; Ohta M; Imamura J; Ikenoue T; Ijichi H; Kawabe T; Isobe T; Omata M
    Oncogene; 2006 Jan; 25(4):633-42. PubMed ID: 16247477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma.
    Ahn J; Hong SA; Lee SE; Kim J; Oh YS; Park SJ; Chung YJ
    Endocr J; 2009; 56(5):707-13. PubMed ID: 19461157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway.
    Cornelius RJ; Si J; Cuevas CA; Nelson JW; Gratreak BDK; Pardi R; Yang CL; Ellison DH
    J Am Soc Nephrol; 2018 Nov; 29(11):2627-2640. PubMed ID: 30301860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.